Literature DB >> 18980728

Chronic depression: update on classification and treatment.

Dana C Torpey1, Daniel N Klein.   

Abstract

A significant proportion of patients with depressive disorders suffer from chronic conditions. The DSM-IV recognizes several forms of chronic depression. Chronic depressions differ from nonchronic major depressive disorder (MDD) on many clinical, psychosocial, and familial variables. However, less support exists for current distinctions between the various forms of chronic depression. Antidepressant medications and at least some forms of psychotherapy are efficacious in treating chronic depression, and the combination of pharmacotherapy and psychotherapy appears to be superior to either monotherapy alone. Still, chronic depression is often inadequately treated, and many patients fail to respond or continue to experience residual symptoms after treatment. An important direction for future research is to elucidate the multiple pathways to chronic depression and to tailor treatments to specific etiopathogenetic subgroups.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18980728     DOI: 10.1007/s11920-008-0074-6

Source DB:  PubMed          Journal:  Curr Psychiatry Rep        ISSN: 1523-3812            Impact factor:   5.285


  37 in total

1.  The distinct temperament profiles of bipolar I, bipolar II and unipolar patients.

Authors:  Hagop S Akiskal; Nael Kilzieh; Jack D Maser; Paula J Clayton; Pamela J Schettler; M Traci Shea; Jean Endicott; William Scheftner; Robert M A Hirschfeld; Martin B Keller
Journal:  J Affect Disord       Date:  2006-04-25       Impact factor: 4.839

2.  Familial aggregation of illness chronicity in recurrent, early-onset major depression pedigrees.

Authors:  Francis M Mondimore; Peter P Zandi; Dean F Mackinnon; Melvin G McInnis; Erin B Miller; Raymond P Crowe; William A Scheftner; Diana H Marta; Myrna M Weissman; Douglas F Levinson; Kathleen P Murphy-Ebenez; J Raymond Depaulo; James B Potash
Journal:  Am J Psychiatry       Date:  2006-09       Impact factor: 18.112

3.  Relative efficacy of psychotherapy and combined therapy in the treatment of depression: a meta-analysis.

Authors:  Saskia M de Maat; Jack Dekker; Robert A Schoevers; Frans de Jonghe
Journal:  Eur Psychiatry       Date:  2006-12-27       Impact factor: 5.361

4.  Differences in the clinical characteristics of adolescent depressive disorders.

Authors:  Linnea Karlsson; Mirjami Pelkonen; Hannele Heilä; Matti Holi; Olli Kiviruusu; Virpi Tuisku; Titta Ruuttu; Mauri Marttunen
Journal:  Depress Anxiety       Date:  2007       Impact factor: 6.505

5.  Plasma testosterone and dehydroepiandrosterone sulfate in male and female patients with dysthymic disorder.

Authors:  Manolis Markianos; John Tripodianakis; Democritos Sarantidis; John Hatzimanolis
Journal:  J Affect Disord       Date:  2006-12-19       Impact factor: 4.839

6.  Does incomplete recovery from first lifetime major depressive episode herald a chronic course of illness?

Authors:  L L Judd; M J Paulus; P J Schettler; H S Akiskal; J Endicott; A C Leon; J D Maser; T Mueller; D A Solomon; M B Keller
Journal:  Am J Psychiatry       Date:  2000-09       Impact factor: 18.112

7.  Ruminative coping among patients with dysthymia before and after pharmacotherapy.

Authors:  Owen Kelly; Kim Matheson; Arun Ravindran; Zul Merali; Hymie Anisman
Journal:  Depress Anxiety       Date:  2007       Impact factor: 6.505

8.  Cognitive self-therapy for chronic depression and anxiety: a multi-centre randomized controlled study.

Authors:  Peter C A M den Boer; Durk Wiersma; Inge Ten Vaarwerk; Mark M Span; A Dennis Stant; Robert J Van den Bosch
Journal:  Psychol Med       Date:  2006-11-01       Impact factor: 7.723

9.  Acute worsening of chronic depression during a double-blind, randomized clinical trial of antidepressant efficacy: differences by sex and menopausal status.

Authors:  Anne T Harvey; Beryl S Silkey; Susan G Kornstein; Cathryn M Clary
Journal:  J Clin Psychiatry       Date:  2007-06       Impact factor: 4.384

10.  Rumination-focused cognitive behaviour therapy for residual depression: a case series.

Authors:  Ed Watkins; Jan Scott; Janet Wingrove; Katharine Rimes; Neil Bathurst; Herbert Steiner; Sandra Kennell-Webb; Michelle Moulds; Yanni Malliaris
Journal:  Behav Res Ther       Date:  2007-03-26
View more
  21 in total

Review 1.  The costs of depression.

Authors:  Ronald C Kessler
Journal:  Psychiatr Clin North Am       Date:  2011-12-16

Review 2.  Personalized medicine in major depressive disorder -- opportunities and pitfalls.

Authors:  Diane B Miller; James P O'Callaghan
Journal:  Metabolism       Date:  2012-09-26       Impact factor: 8.694

Review 3.  The epidemiology of depression across cultures.

Authors:  Ronald C Kessler; Evelyn J Bromet
Journal:  Annu Rev Public Health       Date:  2013       Impact factor: 21.981

4.  Patients Characteristics and Psychosocial Treatment in Psychodynamic and Cognitive Behavior Therapy.

Authors:  Beate Muschalla; Michael Linden; Matthias Rose
Journal:  Front Psychiatry       Date:  2021-05-14       Impact factor: 4.157

Review 5.  Serotonin reuptake inhibitor antidepressants (SSRIs) against atherosclerosis.

Authors:  Greta Wozniak; Aikaterini Toska; Maria Saridi; Odysseas Mouzas
Journal:  Med Sci Monit       Date:  2011-09

Review 6.  Combination of pharmacotherapy and psychotherapy in the treatment of chronic depression: a systematic review and meta-analysis.

Authors:  Alessa von Wolff; Lars P Hölzel; Annika Westphal; Martin Härter; Levente Kriston
Journal:  BMC Psychiatry       Date:  2012-06-13       Impact factor: 3.630

7.  Chronic depression: development and evaluation of the luebeck questionnaire for recording preoperational thinking (LQPT).

Authors:  Tanja Kühnen; Franziska Knappke; Tanja Otto; Stephanie Friedrich; Jan P Klein; Kai G Kahl; Michael Hüppe; Valerija Sipos; Ulrich Schweiger
Journal:  BMC Psychiatry       Date:  2011-12-20       Impact factor: 3.630

8.  Safety and tolerability of vortioxetine (15 and 20 mg) in patients with major depressive disorder: results of an open-label, flexible-dose, 52-week extension study.

Authors:  Paula L Jacobsen; Linda Harper; Lambros Chrones; Serena Chan; Atul R Mahableshwarkar
Journal:  Int Clin Psychopharmacol       Date:  2015-09       Impact factor: 1.659

9.  The effect of qigong on depressive and anxiety symptoms: a systematic review and meta-analysis of randomized controlled trials.

Authors:  Chong-Wen Wang; Cecilia Lai Wan Chan; Rainbow T H Ho; Hector W H Tsang; Celia Hoi Yan Chan; Siu-Man Ng
Journal:  Evid Based Complement Alternat Med       Date:  2013-05-20       Impact factor: 2.629

10.  A comparison of vulnerability factors in patients with persistent and remitting lifetime symptom course of depression.

Authors:  Thorsten Barnhofer; Kate Brennan; Catherine Crane; Danielle Duggan; J Mark G Williams
Journal:  J Affect Disord       Date:  2013-09-20       Impact factor: 4.839

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.